Look for:

Our offer for

MODERNA INC.


ISIN:
US60770K1079
WKN:
60770K107

2022/07/01 22:00:00
Price
149.95 USD
Difference 4.97% (7.10)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)56,930 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)149.95 USD (400)
Ask (Ask size)150.23 USD (200)
Open141.93 USD
High151.10 USD
Low139.54 USD
Close (prev. day)142.85 USD
VWAP148.558805 USD
Volume (pcs)4,838,179
Trading volume718,588,596.86
Number of trades77,526
Last size271,081

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: MODERNA INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/07/01 22:00:00
Price
149.95 USD
Difference 4.97% (7.10)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)56,930 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)149.95 USD (400)
Ask (Ask size)150.23 USD (200)
Open141.93 USD
High151.10 USD
Low139.54 USD
Close (prev. day)142.85 USD
VWAP148.558805 USD
Volume (pcs)4,838,179
Trading volume718,588,596.86
Number of trades77,526
Last size271,081

Performance and Risk

6m1Y3Y
Perf (%)-40.96%-36.22%+917.99%
Perf (abs.)-104.03-85.16+135.22
Beta1.701.220.41
Volatility78.1184.9783.55
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)144.63 USD (4,351,776)
Ø price 30 days | Ø volume 30 days (pcs.)137.26 USD (5,653,827)
Ø price 100 days | Ø volume 100 days (pcs.)147.84 USD (6,761,544)
Ø price 250 days | Ø volume 250 days (pcs.)244.25 USD (11,521,803)
YTD High | date249.42 USD (2022/01/03)
YTD Low | date115.61 USD (2022/06/13)
52 Weeks High | date497.49 USD (2021/08/10)
52 Weeks Low | date115.61 USD (2022/06/13)

All listings for MODERNA INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/07/0117:35144.00 EUR2.19257
Vienna Stock Exchange2022/07/0111:00137.54 EUR0.011
Tradegate2022/07/0122:27143.76 EUR3.22215
Stuttgart2022/07/0121:47143.80 EUR0.1413
Nasdaq2022/07/0122:00149.95 USD718.5977,526
Munich2022/07/0108:02134.98 EUR0.001
London Stock Exchange European Trade Reporting2022/07/0117:30149.31 USD0.0025
Hanover2022/07/0108:02134.42 EUR0.001
Hamburg2022/07/0115:54140.92 EUR0.002
Frankfurt2022/07/0120:11143.00 EUR0.1112
Duesseldorf2022/07/0119:30142.72 EUR0.007
Berlin2022/07/0121:45143.60 EUR0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=144067&ID_TYPE_IMAGE_LOGO=2

Contact Details

MODERNA INC.
- -
200 Technology Square - 02139 Cambridge
Telefon: 1-617-714-6500
Fax: 617-583-1998
E-mail: info@modernatx.com

PDF Downloads

Company report: MODERNA INC.PDF Download

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Members of Management Board

Noubar AfeyanChairman of Board of Directors
Elizabeth NabelMember of Board of Directors
Francois NaderMember of Board of Directors
Robert LangerMember of Board of Directors
Sandra HorningMember of Board of Directors
Elizabeth TallettMember of Board of Directors
Paul SaganMember of Board of Directors
Stephen BerensonMember of Board of Directors
Stéphane BancelChairman of Managing Board
Corinne Le GoffMember of Executive Committee
David MelineMember of Executive Committee
Juan AndresMember of Executive Committee
Kate CroninMember of Executive Committee
Marcello DamianiMember of Executive Committee
Paul Burton, M.D.Member of Executive Committee
Shannon Thyme KlingerMember of Executive Committee
Stephen Hoge, M.D.Member of Executive Committee
Tracey FranklinMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer